1. A conventional immune regulator mitochondrial antiviral signaling protein blocks hepatic steatosis by maintaining mitochondrial homeostasis
- Author
-
Lan Bai, Wen-Jie Zhao, Tengfei Ma, Manli Hu, Fengjiao Hu, Chongshu Jian, Han Tian, Xu Cheng, Jiajun Fu, Yanfang Zhang, Juan Yang, Zhi-Gang She, Yan-Xiao Ji, Junjie Zhou, Xiao-Jing Zhang, Peng Zhang, Yan Zhang, Jingwei Jiang, and Hongliang Li
- Subjects
Male ,Primary Cell Culture ,Regulator ,Down-Regulation ,Biology ,Mice ,Immune system ,Downregulation and upregulation ,Non-alcoholic Fatty Liver Disease ,Nonalcoholic fatty liver disease ,Hepatic Stellate Cells ,medicine ,Animals ,Homeostasis ,Humans ,Metabolomics ,Cells, Cultured ,Adaptor Proteins, Signal Transducing ,Mitochondrial antiviral-signaling protein ,Mice, Knockout ,Hepatology ,Voltage-Dependent Anion Channel 2 ,Lipogenesis ,medicine.disease ,digestive system diseases ,Mitochondria ,Cell biology ,Gene Knockdown Techniques ,Knockout mouse ,Disease Progression ,Hepatocytes ,Steatosis ,VDAC2 - Abstract
Background & aims Although the prevalence of nonalcoholic fatty liver disease (NAFLD) has risen dramatically to 25% of the adult population worldwide, there are as yet no approved pharmacological interventions for the disease due to uncertainty about the underlying molecular mechanisms. It is known that mitochondrial dysfunction is an important factor in the development of NAFLD. Mitochondrial antiviral signaling protein (MAVS) is a critical signaling adaptor for host defenses against viral infection. However, the role of MAVS in mitochondrial metabolism during NAFLD progression remains largely unknown. Approach & results Based on expression analysis, we identified a marked downregulation of MAVS in hepatocytes during NAFLD progression. By employing MAVS global knockout and hepatocyte-specific MAVS knockout mice, we found that MAVS is protective against diet-induced NAFLD. MAVS deficiency induces extensive mitochondrial dysfunction during NAFLD pathogenesis which was confirmed as impaired mitochondrial respiratory capacity and membrane potential. Metabolomics data also showed the extensive metabolic disorders after MAVS deletion. Mechanistically, MAVS interacts with the N-terminal stretch of voltage-dependent anion channel 2 (VDAC2), which is required for the ability of MAVS to influence mitochondrial function and hepatic steatosis. Conclusions In hepatocytes, MAVS plays an important role in protecting against NAFLD by helping to regulate healthy mitochondrial function. These findings provide new insights regarding the metabolic importance of conventional immune regulators and support the possibility that targeting MAVS may represent a new avenue for treating NAFLD.
- Published
- 2021